Cardiovascular disease (CVD) has been the 
major cause of death worldwide for many
years. Comorbidities include obesity, 
altered lipid profiles, and insulin resistance
are frequently linked to CVD. For obesity, 
it is one of the largest and fastest growing 
public health problems in the world. The
pharmacological options for obesity 
treatment remain quite limited. Recently,
one of the potential exciting research areas
is the development of innovative 
therapeutic molecular vaccines and
immunoglobulins.